Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins

Barth, Stefan; Grawunder, Ulf

Springer International Publishing AG

07/2018

181

Mole

Inglês

9783319836096

15 a 20 dias

454

Descrição não disponível.
Chemical Assembly of Antibody-Drug Conjugates.- Pre-clinical evaluation of ADCs delivering highly potent pyrrolobenzodiazepine (PBD) dimers.- Stable and homogeneous drug conjugation by sequential bis-alkylation at disulfide bonds using bis-sulfone reagents.- Calicheamicin antibody-drug conjugates for liquid- and solid tumor indications.- Enzyme-based strategies to generate site-specifically conjugated Antibody Drug Conjugates.- Substance P - Saporin for the Treatment of Intractable Pain.- Recombinant immunotoxins for Chronic Inflammatory Disease.- BL22: A milestone in targeting CD22.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Antibody based cancer therapy;Antibody drug conjugates (ADC);Immunotoxin development;Pyrrolobenzodiazepines;Calicheamicin;Substance P-Saporin;antibodies;pharmacotherapy